⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for 89Zr-KN035 PET Imaging in Patients With Advanced Solid Tumors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: 89Zr-KN035 PET Imaging in Patients With Advanced Solid Tumors

Official Title: 89Zr-labeled KN035 PET Imaging in Patients With PD-L1positive Advanced Solid Tumors

Study ID: NCT03638804

Interventions

89Zr-KN035

Study Description

Brief Summary: This is a single arm study by using 89Zr-labeled KN035 (89Zr-KN035) PET imaging to evaluate the biodistribution and target lesion uptake of 89Zr-KN035 in patients with PD-L1 positive advanced solid tumors.

Detailed Description: The overall purpose of the study is to evaluate the biodistribution and target lesion uptake of 89Zr-KN035 in patients with PD-L1 positive advanced solid tumors by using PET imaging. Safety will be observed after 89Zr-KN035 injection, and radiation dosimetry of 89Zr-KN035 will be calculated.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China

Contact Details

Name: Liyan Miao, PhD

Affiliation: The First Affiliated Hospital of Soochow University

Role: PRINCIPAL_INVESTIGATOR

Name: Jianan Huang, PhD

Affiliation: The First Affiliated Hospital of Soochow University

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: